These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6819280)

  • 1. The myxovirescins, a family of antibiotics from Myxococcus virescens (Myxobacterales).
    Gerth K; Irschik H; Reichenbach H; Trowitzsch W
    J Antibiot (Tokyo); 1982 Nov; 35(11):1454-9. PubMed ID: 6819280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The myxovalargins, new peptide antibiotics from Myxococcus fulvus (Myxobacterales). I. Cultivation, isolation, and some chemical and biological properties.
    Irschik H; Gerth K; Kemmer T; Steinmetz H; Reichenbach H
    J Antibiot (Tokyo); 1983 Jan; 36(1):6-12. PubMed ID: 6432761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A macrocyclic antibiotic M-230B produced by Myxococcus xanthus. Isolation and characterization.
    Onishi N; Izaki K; Takahashi H
    J Antibiot (Tokyo); 1984 Jan; 37(1):13-9. PubMed ID: 6421789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production, isolation, physico-chemical and biological properties of angiolam A, a new antibiotic from Angiococcus disciformis (Myxobacterales).
    Kunze B; Kohl W; Höfle G; Reichenbach H
    J Antibiot (Tokyo); 1985 Dec; 38(12):1649-54. PubMed ID: 3937837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The myxopyronins, new inhibitors of bacterial RNA synthesis from Myxococcus fulvus (Myxobacterales).
    Irschik H; Gerth K; Höfle G; Kohl W; Reichenbach H
    J Antibiot (Tokyo); 1983 Dec; 36(12):1651-8. PubMed ID: 6420386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and partial characterization of an antibiotic produced by Myxococcus xanthus.
    Vaks B; Zuckerberg A; Rosenberg E
    Can J Microbiol; 1974 Feb; 20(2):155-61. PubMed ID: 4362757
    [No Abstract]   [Full Text] [Related]  

  • 7. Myxothiazol, an antibiotic from Myxococcus fulvus (myxobacterales). I. Cultivation, isolation, physico-chemical and biological properties.
    Gerth K; Irschik H; Reichenbach H; Trowitzsch W
    J Antibiot (Tokyo); 1980 Dec; 33(12):1474-9. PubMed ID: 6788741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The myxalamids, new antibiotics from Myxococcus xanthus (Myxobacterales). I. Production, physico-chemical and biological properties, and mechanism of action.
    Gerth K; Jansen R; Reifenstahl G; Höfle G; Irschik H; Kunze B; Reichenbach H; Thierbach G
    J Antibiot (Tokyo); 1983 Sep; 36(9):1150-6. PubMed ID: 6415031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel macrocyclic antibiotics: megovalicins A, B, C, D, G and H. II. Isolation and chemical structures of megovalicins.
    Takayama S; Yamanaka S; Miyashiro S; Yokokawa Y; Shibai H
    J Antibiot (Tokyo); 1988 Apr; 41(4):439-45. PubMed ID: 3131290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stigmatellin, a new antibiotic from Stigmatella aurantiaca (Myxobacterales). I. Production, physico-chemical and biological properties.
    Kunze B; Kemmer T; Höfle G; Reichenbach H
    J Antibiot (Tokyo); 1984 May; 37(5):454-61. PubMed ID: 6429114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tartrolons, new boron-containing antibiotics from a myxobacterium, Sorangium cellulosum.
    Irschik H; Schummer D; Gerth K; Höfle G; Reichenbach H
    J Antibiot (Tokyo); 1995 Jan; 48(1):26-30. PubMed ID: 7532644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bactericidal action of an antibiotic produced by Myxococcus xanthus.
    Rosenberg E; Vaks B; Zuckerberg A
    Antimicrob Agents Chemother; 1973 Nov; 4(5):507-13. PubMed ID: 4208901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myxovirescin analogues via macrocyclic ring-closing metathesis.
    Content S; Dutton CJ; Roberts L
    Bioorg Med Chem Lett; 2003 Feb; 13(3):321-5. PubMed ID: 12565921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological activity of an antibiotic produced by Myxococcus coralloides.
    Arias JM; Rodriguez C; Montoya E
    Microbios; 1979; 24(96):123-31. PubMed ID: 120482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saframycin Mx1, a new natural saframycin isolated from a myxobacterium.
    Irschik H; Trowitzsch-Kienast W; Gerth K; Höfle G; Reichenbach H
    J Antibiot (Tokyo); 1988 Aug; 41(8):993-8. PubMed ID: 2459096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic activity of myxobacteria in relation to their bacteriolytic capacity.
    NOREN B; RAPER KB
    J Bacteriol; 1962 Jul; 84(1):157-62. PubMed ID: 14480333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The primary structure of fulvocin C from Myxococcus fulvus.
    Tsai H; Hirsch HJ
    Biochim Biophys Acta; 1981 Jan; 667(1):213-7. PubMed ID: 6783114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malioxamycin, a new antibiotic with spheroplast-forming activity. I. Producing organism, fermentation, isolation and characterization.
    Takeuchi M; Inukai M; Enokita R; Iwado S; Takahashi S; Arai M
    J Antibiot (Tokyo); 1980 Nov; 33(11):1213-9. PubMed ID: 7019175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corallorazines from the myxobacterium Corallococcus coralloides.
    Schmitz A; Kehraus S; Schäberle TF; Neu E; Almeida C; Roth M; König GM
    J Nat Prod; 2014 Jan; 77(1):159-63. PubMed ID: 24422674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel macrocyclic antibiotics: megovalicins A, B, C, D, G and H. I. Screening of antibiotics-producing myxobacteria and production of megovalicins.
    Miyashiro S; Yamanaka S; Takayama S; Shibai H
    J Antibiot (Tokyo); 1988 Apr; 41(4):433-8. PubMed ID: 3131289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.